BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19144156)

  • 41. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.
    Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC
    Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors.
    Tarkkanen M; Kiuru-Kuhlefelt S; Blomqvist C; Armengol G; Böhling T; Ekfors T; Virolainen M; Lindholm P; Monge O; Picci P; Knuutila S; Elomaa I
    Cancer Genet Cytogenet; 1999 Oct; 114(1):35-41. PubMed ID: 10526533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of EWSR1 translocation with nuclear extraction-based fluorescence in situ hybridization for diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor.
    Yang Y; Zhang L; Wei Y; Wang H; Xiong W; Chen Z; Hes O; Zheng J
    Anal Quant Cytol Histol; 2007 Aug; 29(4):221-30. PubMed ID: 17879630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma.
    Sorensen PH; Wu JK; Berean KW; Lim JF; Donn W; Frierson HF; Reynolds CP; López-Terrada D; Triche TJ
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1038-43. PubMed ID: 8577710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene expression profile of ewing sarcoma cell lines differing in their EWS-FLI1 fusion type.
    Bandrés E; Malumbres R; Escalada A; Cubedo E; González I; Honorato B; Zarate R; García-Foncillas J; de Alava E
    J Pediatr Hematol Oncol; 2005 Oct; 27(10):537-42. PubMed ID: 16217257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.
    Le Deley MC; Delattre O; Schaefer KL; Burchill SA; Koehler G; Hogendoorn PC; Lion T; Poremba C; Marandet J; Ballet S; Pierron G; Brownhill SC; Nesslböck M; Ranft A; Dirksen U; Oberlin O; Lewis IJ; Craft AW; Jürgens H; Kovar H
    J Clin Oncol; 2010 Apr; 28(12):1982-8. PubMed ID: 20308673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arrangement of chromosome 11 and 22 territories, EWSR1 and FLI1 genes, and other genetic elements of these chromosomes in human lymphocytes and Ewing sarcoma cells.
    Taslerová R; Kozubek S; Lukásová E; Jirsová P; Bártová E; Kozubek M
    Hum Genet; 2003 Feb; 112(2):143-55. PubMed ID: 12522555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytogenetic and molecular cytogenetic studies of a variant of t(21;22), ins(22;21)(q12;q21q22), with a deletion of the 3' EWSR1 gene in a patient with Ewing sarcoma.
    Lee J; Hopcus-Niccum DJ; Mulvihill JJ; Li S
    Cancer Genet Cytogenet; 2005 Jun; 159(2):177-80. PubMed ID: 15899394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma.
    Ban J; Bennani-Baiti IM; Kauer M; Schaefer KL; Poremba C; Jug G; Schwentner R; Smrzka O; Muehlbacher K; Aryee DN; Kovar H
    Cancer Res; 2008 Sep; 68(17):7100-9. PubMed ID: 18757425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
    Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
    Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
    Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
    J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The EWS gene rearrangement in Ewing tumors: key to the disease].
    Kovar H; Zoubek A; Pfleiderer C; Jug G; Auinger A; Aryee D; Ambros PF; Salzer-Kuntschik M; Amann G; Windhager R
    Klin Padiatr; 1994; 206(4):196-200. PubMed ID: 7967416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
    Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
    J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular diagnosis of Ewing tumors: improved detection of EWS-FLI-1 and EWS-ERG chimeric transcripts and rapid determination of exon combinations.
    Meier VS; Kühne T; Jundt G; Gudat F
    Diagn Mol Pathol; 1998 Feb; 7(1):29-35. PubMed ID: 9646032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
    Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
    Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA.
    Hayashi M; Chu D; Meyer CF; Llosa NJ; McCarty G; Morris CD; Levin AS; Wolinsky JP; Albert CM; Steppan DA; Park BH; Loeb DM
    Cancer; 2016 Oct; 122(19):3015-23. PubMed ID: 27351911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
    Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
    Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue.
    Gierisch ME; Pfistner F; Lopez-Garcia LA; Harder L; Schäfer BW; Niggli FK
    J Biol Chem; 2016 Dec; 291(52):26922-26933. PubMed ID: 27875302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion.
    Sadri N; Barroeta J; Pack SD; Abdullaev Z; Chatterjee B; Puthiyaveettil R; Brooks JS; Barr FG; Zhang PJ
    Virchows Arch; 2014 Aug; 465(2):233-9. PubMed ID: 24993903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
    Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
    Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.